TransEnterix Announces First Human Cases Using Its Advanced Energy Device
Business Wire - Wed Apr 16, 6:01AM CDT
TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced the first human cases performed using its recently launched fully flexible advanced energy device.
TransEnterix, Inc. Announces Proposed Public Offering of Common Stock
Business Wire - Wed Apr 02, 4:21PM CDT
TransEnterix, Inc. (OTCBB:TRXCD), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced it intends to offer shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. TransEnterix plans to use the net proceeds from this offering for research and development, sales and marketing, and commercialization related to its SurgiBot(TM) system, working capital and other general corporate purposes.
TransEnterix, Inc. Announces NYSE MKT Market Listing Plans and Reverse Stock Split
Business Wire - Tue Apr 01, 4:15PM CDT
TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced that it has received authorization to list its common shares on the NYSE MKT. In addition, its Board of Directors has approved a 1-for-5 reverse split of its issued and outstanding shares of common stock, which became effective on March 31, 2014. Trading of the Company's common shares will reflect the reverse stock split on April 2, 2014.
TransEnterix, Inc. Files Pre-Submission Documentation with FDA Regarding its SurgiBot System
Business Wire - Mon Mar 31, 3:30PM CDT
TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced that it has completed a pre-submission filing with the U.S. Food and Drug Administration ("FDA"
TransEnterix, Inc. Provides Update on Investor & Analyst Event
Business Wire - Tue Mar 25, 3:30PM CDT
TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve the experience and outcomes of minimally invasive surgery, today announced it has postponed its Investor & Analyst Event previously-scheduled for April 3, 2014 in Salt Lake City due to a scheduling conflict with senior management. The Company continues to remain on track to complete its 2014 Key Objectives as outlined in the Company's March 6, 2014 press release, including completing a pre-submission FDA filing for the SurgiBot(TM) system in the first quarter. The Company is in the process of identifying an alternative date and location for the event.
TransEnterix, Inc. Reports Operating Results for the Fourth Quarter and Full Year 2013
Business Wire - Wed Mar 05, 6:00AM CST
TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve how minimally invasive surgery is performed, today announced its operating and financial results for the fourth quarter and full year 2013, as well as its 2014 key objectives.
CORRECTING and REPLACING TransEnterix Schedules Fourth Quarter and Full Year 2013 Earnings Release and Conference Call for March 5, 2014
Business Wire - Wed Feb 26, 4:23PM CST
First graph, end of second sentence of release should read: ...starting at 8:00 am Eastern Time the same day. (sted ...starting at 1:00 pm Eastern Time the same day.).
TransEnterix Schedules Fourth Quarter and Full Year 2013 Earnings Release and Conference Call for March 5, 2014
Business Wire - Wed Feb 26, 3:56PM CST
TransEnterix, Inc. (OTCBB: TRXC) announced today that it plans to release fourth quarter and full year 2013 financial and operating results prior to the market open on Wednesday, March 5, 2014. Todd Pope, Chief Executive Officer and Joe Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these resulting starting at 1:00 pm Eastern Time the same day. The call will be concurrently webcast.
TransEnterix, Inc. to present at the RBC Capital Markets 2014 Healthcare Conference
Business Wire - Tue Feb 11, 3:32PM CST
TransEnterix, Inc. (OTCBB:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the RBC Capital Markets 2014 Healthcare Conference in New York. The presentation is scheduled to take place at 2:35 pm Eastern Time on Tuesday, February 25, 2014.
TransEnterix Enters Next Phase of Development of SurgiBot(TM) System
Business Wire - Mon Jan 13, 6:00AM CST
TransEnterix, Inc. (OTCBB: TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced that multiple surgeons have used SurgiBot, the company's patient-side minimally invasive robotic system, to successfully complete general surgery procedures in the porcine model. The procedures performed in the pre-clinical testing included cholecystectomy and sleeve gastrectomy.